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Objective: To report the clinical features and management of seven cases of intraocular 
inflammation caused by Rickettsia infection and review published literature.
Methods: Rickettsia conorii or Rickettsia spp. infection was diagnosed based on the following 
criteria: (1) positive serology according to the European Guidelines, (2) titer normalization 
after specific treatment, and (3) complete resolution of ophthalmic disease and accompanying 
  symptoms after antibiotic therapy.
Results: Seven patients were referred for uveitis of unknown etiology. All came from regions 
where Mediterranean spotted fever is prevalent. One patient met the European guidelines 
criteria for Rickettsia spp. infection, while the other six cases met the criteria for R. conorii 
infection. The main symptoms were visual loss, floaters, eye redness, photophobia, and ocu-
lar pain. Predominant ophthalmic signs included vasculitis, choroiditis, vitritis, and macular 
edema. All patients required antibiotic treatment that resulted in the remission of the infection. 
Doxycycline was the first choice and the only antibiotic used to treat four patients. One patient 
needed ciprofloxacin as a second antibiotic after not responding to doxycycline. Two patients 
had doxycycline as a second antibiotic after not responding primarily to sulfonamides (which 
had been given after 2–3 days of doxycycline gastric intolerance); one of these patients needed 
ciprofloxacin as a third antibiotic.
Conclusion: Intraocular inflammation can occur as the main manifestation of Rickettsia conorii 
or Rickettsia spp. infection. It should be considered as a differential diagnosis for uveitis espe-
cially for patients living in countries where this infection is endemic in the world. Antibiotic 
treatment remains effective in the management of Rickettsia infection.
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Introduction
Mediterranean spotted fever (MSF) or boutonneuse fever is an acute systemic 
disease, first described in 1910 in Tunisia by Conor and Bruch.1 It is transmitted to 
humans by tick bites. The etiologic agent is Rickettsia conorii, a small coccobacillary 
intracellular bacterium belonging to the spotted fever group of the Rickettsia family.2 
MSF is an endemic disease occurring during spring and summer in Asia, Africa, and 
Mediterranean countries.3 The pathophysiology of R. conorii infection is characterized 
by vascular invasion causing injury and tissue necrosis.4 Endothelial cells are the 
organism’s main target.4
In addition to general malaise, the clinical symptoms of Rickettsia infection include 
the triad of fever, skin rash, and headaches. There are many reports on the systemic 
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are scarce. The existing reports are short communications 
or correspondence and describe ocular manifestations that 
include conjunctivitis, keratitis, anterior uveitis, panuveitis, 
retinitis, retinal vascular   occlusions, retinal vasculitis, 
intraretinal hemorrhages, macular edema, macular star, optic 
disc edema, optic neuritis, and multiple evanescent white dot 
syndrome-like lesions.1,2,5–22
Guidelines for the diagnosis of tick-borne bacterial diseases 
in Europe have been reported, and consequently serologic 
antibody titers for the diagnosis of R. conorii and other Rick-
ettsia spp. infections have been standardized.23 We describe the 
largest reported series to date of R. conorii and Rickettsia spp. 
infection with uveitis as the predominant manifestation.
Materials and methods
Seven patients diagnosed with uveitis due to Rickettsia 
infection and cared for at the Ocular Immunology and Uveitis 
Unit of IOBA, University of Valladolid, Spain, between 
May 1999 and March 2006, were identified from a database. 
We performed the retrospective portion of this study by 
reviewing clinical histories. Beginning in March 2005, patients 
were prospectively followed. The Ethics Committee of the 
University of Valladolid approved this study. Each patient 
completed a detailed uveitis questionnaire at the initial visit. 
Comprehensive family, personal, and ophthalmic histories 
were obtained. A complete ocular examination was performed 
at every visit, including best-corrected visual acuity, slit-lamp 
examination, tonometry, and ophthalmoscopy. Fluorescein 
angiography or other tests were performed when considered 
necessary. Uveitis was classified as anterior, intermediate, 
posterior, or panuveitis.24 Demographic data were recorded 
to include age, race, gender, city of origin, systemic signs 
and symptoms, previous treatments, serologies, and treatment 
initiated at our institution. We also recorded the delay to 
diagnosis as the elapsed time between initial symptoms and 
our diagnosis and the follow-up time as the elapse period 
between diagnosis of rickettsiosis and last visit. Additionally, 
the average time to achieve therapeutic success was recorded 
as the elapsed time between last antibiotic treatment and the 
last visit. Clinical findings and follow-up results were recorded. 
Ocular symptoms and signs were recorded by eye.
According to the guidelines for the diagnosis of tick-
borne bacterial diseases in Europe,23 diagnostic criteria 
for R. conorii infection in suspected cases of MSF are IgG 
titers $128 and/or IgM titers $64 as determined by serum 
immunofluorescence. IgG titers $64 and/or IgM titers $32 
are considered indicative of infection by other R. spp.23 
We considered that to diagnose a uveitis case as caused 
by Rickettsia, the three following criteria had to be met: 
(1) positive serology by ELISA testing according to the 
European guidelines as stated above, (2) normalization of 
antibody titers 3 months after specific antibiotic treatment, 
and (3) complete resolution of ophthalmic disease and 
accompanying symptoms. This last criterion means that 
diagnosed patients had to be cured (absence of symptoms, 
no inflammatory cells, and disappearance of all active signs 
of inflammation) with no further recurrence. The patient 
was considered “cured” when titers became negative and 
inflammation disappeared and did not recur.
Results
Demographic and extraocular findings are reported in Table 1, 
whereas variables concerning ophthalmic involvement are 
shown in Table 2. A total of ten eyes of seven Caucasian 
subjects, four males and three females, 39.1 ± 16.0 years old 
(mean ± SD; range: 8–54; median: 43 years) were included in 
this study. The mean follow-up time was 46.4 ± 26.9 months 
(range: 12–84 months; median: 40 months). The mean 
follow-up of elapsed time between the last successful 
antibiotic treatment and last visit was 35.2 ± 29.6 months 
(range: 6–72 months; median: 20 months). Six patients came 
from Extremadura in the southwest region of Spain and one 
from Andalucia in the southernmost region.
The main symptoms included loss of vision in seven 
eyes and floaters in four eyes. Less frequently, the patients 
presented with redness, photophobia, and pain. Ophthalmic 
examinations revealed vitritis in nine eyes, macular edema in 
five eyes, and vasculitis, the predominant feature as expected, 
in six eyes. The vasculitis was venous and focal in nature 
with sheathing and mild leakage in all cases, except in Case 
5, where phlebitis was more diffuse. Other ophthalmic signs 
included central retinal vein thrombosis in Case 5 (Figure 1A 
and 1B), due to venous inflammation, focal choroiditis, 
multifocal choroiditis, focal keratopathy, anterior chamber 
cells, posterior synechiae, retinal hemorrhages, and papillitis. 
Four cases were unilateral and three were bilateral. All patients 
had frequent contact with dogs and two patients were aware 
of insect bites, including one by tick and one by flea. One of 
the two patients recalled a cutaneous lesion compatible with 
erythema migrans after a tick bite. Three patients described 
transient extraocular manifestations of arthralgias and fever 
that had already disappeared before their first visit with us.
Our choice of antibiotic treatment followed the guidelines 
proposed by Raoult et al.25 One antibiotic course of treatment 
(doxycycline 100 mg/12 hours for 8–10 weeks) was sufficient 
in four patients (Cases 1, 2, 3, and 5). Two courses were Clinical Ophthalmology 2011:5 submit your manuscript | www.dovepress.com
Dovepress 
Dovepress
1403
Intraocular inflammation in R. conorii infection
required in three patients (Cases 6 and 7), and three antibiotic 
courses were required for remission in one patient (Case 4). 
Doxycycline was always our first choice and was enough to 
cure the infection in four patients. Two more patients, however 
(Cases 4 and 6) reported gastric complaints after 2–3 days on 
doxycycline and we switched them to the fixed combination, 
80 mg trimethoprim–400 mg sulfamethoxazole/12 hours 
for 8–10 weeks, following advice of the referring internist. 
After failure of this antibiotic, they were given doxycycline 
again, this time with strict gastric protection; although still 
some gastric complaints were present, patients were able to 
complete the entire treatment. One of them (Case 6) was 
cured, and the other one (Case 4) required a third treatment 
(Figure 2A to 2D) with 750 mg/12 hours for 10 days of oral 
ciprofloxacin. Serology tests were negative in all patients 
when re-tested 3 and 6 months after the end of the antibiotic 
therapy.
Discussion
Rickettsia species are obligate intracellular organisms, with 
vascular tropism, that survive in mammalian reservoirs and 
insect vectors. The taxonomy of the Rickettsia genus has 
undergone significant reorganization in the last decade. 
Humans are usually incidental hosts, who are infected by the 
bite during feeding of contaminated arthropods such as ticks, 
mites, fleas, and lice.3 These zoonoses, caused by Rickettsia 
species, can be classified into three groups: (1) rickettsiosis due 
to bacteria of the genus Rickettsia, including the spotted fever 
group (SFG) and the typhus group Rickettsiae; R. rickettsii 
is responsible for rocky mountain spotted fever (RMSF), 
R. conorii for MSF; (2) ehrlichioses and anaplasmoses, due 
to bacteria within the family Anaplasmataceae; and (3) scrub 
typhus, due to Orientia tsutsugamushi.23
Rickettsioses from the SFG, perhaps the best known, 
are characterized by development of tache noir at the site 
of the arthropod bite, high fever, myalgia, headaches, and 
occasional gastrointestinal and neurological signs. RMSF 
is an important human rickettsiosis in the United States, 
but other rickettsial spotted fevers are encountered mostly 
in other continents.26,27 For RMSF, the systemic disease 
can be accompanied by bilateral optic disk edema, cotton-
wool spots, and tortuous retinal veins.28 In other cases with 
no systemic manifestations, RMSF can present as keratic 
precipitates, anterior chamber and vitreous cells, optic disc 
edema, retinal hemorrhages, retinal arteriolar sheathing, and 
macular star.29
The dog tick Rhipicephalus sangineus, which inoculates 
R. conorii into the skin while feeding, transmits MSF. Patients 
present with a characteristic tache noir in 50%–75% of 
cases and systemic disease one week after contact. They 
have a good prognosis.26 The pathophysiologic hallmark is 
vascular endothelial cell invasion by the organism, causing 
endothelial injury and tissue necrosis. It is an endemic disease 
in Mediterranean countries, including Spain, with reported 
cases in the regions of Extremadura, Andalucia, Castilla y 
León, and the east coast.30–32 R. conorii, R. mongolotimonae, 
Table 1 Patient demographics and extraocular findings
Case Age/ 
sex
Region of  
origin in  
Spain
Anti-R. conorii titers  
IgG; IgM (ELISA)
Extraocular  
findings
Total FU  
(months)
Diagnosis 
delay  
(months)
Antibiotic  
treatment
Elapsed time  
of last antibiotic 
treatment to  
last FU (months)
Pre-  
antibiotic
3 months  
post-
antibiotic
1 33/M extremadura  
(Cáceres)
1/40;  
1/80
Negative;  
Negative
None 84 11 Doxycycline 72
2 8/M extremadura  
(Cáceres)
1/40;  
1/40
Negative;  
Negative
Arthralgia  
Fever
75 2 Doxycycline 72
3 43/M Andalucía  
(Almería)
1/160;  
1/40
Negative;  
Negative
None 59 3 Doxycycline 54
4 54/F extremadura  
(Cáceres)
1/160;  
1/80
Negative;  
Negative
None 40 3 TMP-sFX  
doxycycline  
ciprofloxacin
12
5 35/M extremadura  
(Cáceres)
1/80;  
1/80
Negative;  
Negative
erythema migrans  
after tick bite
30 2 Doxycycline 20
6 51/F extremadura  
(Badajoz)
1/320;  
1/20
Negative;  
Negative
Arthralgia 25 1 TMP-sFX  
doxycycline
11
7 50/F extremadura  
(Badajoz)
1/40;  
1/160
Negative;  
Negative
Arthralgia  
Flea bites
12 2 Doxycycline  
ciprofloxacin
16
Note: TMP-sFX combination was given 2–3 days after patients reported gastric complaints with doxycycline. After therapeutic failure, doxycyline was given again with gastric 
precaution to complete the treatment regimen. 
Abbreviations: FU, follow-up; TMP-sFX, trimethoprim-sulfamethoxazole.Clinical Ophthalmology 2011:5 submit your manuscript | www.dovepress.com
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Table 2 Description of ocular pathology and results at end of follow-up
Case Eye Initial  
(referral)  
diagnosis
Ocular  
symptoms
Type of  
uveitis*
Pathologic ocular  
signs at first visit**
Pathologic ocular  
signs at end of FU/  
(time to reach clinical 
remission after  
antibiotic treatment)*
BCVA at  
end of  
FU/reason  
for visual loss
Worst   
BCVA   
on FU
1 Os Uveitis  
due to 
toxoplasmosis
Loss of vision  
Floaters
Posterior +1 Vitritis  
Vasculitis  
Choroiditis  
retinal hemorrhages
Peripheral retinal vessel  
attenuation  
Foveal ischemia  
(12 weeks)
0.100  
Foveal ischemia
0.100
2 OD idiopathic 
panuveitis
Asymptomatic Posterior +1 Vitritis None  
(4 weeks)
1.000 0.900
Os idiopathic  
panuveitis
Loss of vision  
redness  
Photophobia
Panuveitis +2 Anterior  
chamber cells  
Posterior synechiae  
+2 Vitritis  
retinitis  
Diffuse macular  
edema
subtle retinal pigment  
epithelial changes  
(12 weeks)
1.000 0.500
3 OD idiopathic  
uveitis
Loss of vision  
Floaters
Posterior sub-foveal lesion Foveal scar  
(12 weeks)
0.500  
Foveal scar,  
cataract
0.500
4 OD idiopathic  
uveitis
Floaters Posterior +1 Vitritis  
Vasculitis  
Choroiditis
None  
(8 weeks after  
3rd antibiotic;  
6 months after  
1st antibiotic)
1.000 0.800
Os idiopathic  
uveitis
Floaters Posterior +1 Vitritis  
Vasculitis  
Choroiditis  
Macular edema
None  
(8 weeks after  
3rd antibiotic;  
6 months after  
1st antibiotic)
1.000 0.300
5 OD idiopathic  
retinal central  
vein thrombosis
Loss of vision Posterior +2 Vitritis  
Vasculitis (phlebitis)  
retinal venous  
tortuosity  
retinal hemorrhages  
Macular edema
None  
(8 weeks)
1.000 0.400
6 OD idiopathic  
intermediate  
uveitis
redness  
Pain  
Blurred vision
Panuveitis Anterior chamber  
cells  
Posterior synechiae  
+1 Vitritis  
Vitreous exudates  
retinal hemorrhages
None  
(8 weeks after  
2nd antibiotic;  
4 months after  
1st antibiotic)
1.000 0.800
7 OD Panuveitis VKH Loss of vision Posterior +2 Vitritis  
Vasculitis  
Choroiditis  
Macular edema
Focal choroidal scars  
Vascular attenuation  
Chronic macular edema  
(4 weeks after  
2nd antibiotic;  
3 months after  
1st antibiotic)
0.200  
Chronic macular  
edema  
Cataract
0.100
Os Panuveitis VKH Loss of vision Posterior +2 Vitritis  
Vasculitis  
Disseminated   
choroiditis  
Focal nodules  
Macular edema
Focal choroidal scars  
Vascular attenuation  
Chronic macular edema  
(4 weeks after  
2nd antibiotic; 
4 months after  
1st antibiotic)
0.300  
Chronic macular  
edema  
Cataract
0.160
Notes:  *Uveitis  classification  according  to  anatomic  location;24 **Grading  of  anterior  chamber  cells  and  vitreous  cells  (vitritis)  according  to  sUN  working  group.24 
Abbreviations: OD, right eye; Os, left eye; OU, both eyes; BCVA, best corrected visual acuity; FU, follow-up; VKH, Vogt-Koyanagi-Harada.Clinical Ophthalmology 2011:5 submit your manuscript | www.dovepress.com
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R. slovaca, and R. helvetica are the species reported in these 
areas.32 The last two have been associated with atypical MSF, 
without exanthem.32
All our patients were originally from the regions of 
Extremadura and Andalucia, where MSF is endemic. Most 
of our patients could not remember a history of insect 
bites, but could not deny it either. In general, 73% of 
patients deny having a history of tick bite, which agrees 
with our series, where only two patients reported insect 
bites.32
Although most of our patients had no typical systemic 
manifestations of MSF, they did have positive serology for R. 
conorii or Rickettsia spp. infection. Cases 2, 6, and 7 had a 
previous history of arthralgias, which can be caused by these 
or other entities. In Case 2, the child’s uveitis   (Figure 3A to 
3C) was diagnosed 3 months before a reported fever episode 
and appearance of a hyperemic papule. He had IgM titers of 
1/40, which met European criteria for Rickettsia spp. infec-
tion.23 All individuals in this series except Case 2 had IgG 
and/or IgM levels that met European criteria for R. conorii 
infection.23
Ocular involvement in MSF commonly occurs as vascu-
litis (55.9%), choroiditis (16.7%), serous retinal detachment 
(5%), cystoid macular edema (1.7%), and others.15,26,32 
  Keratitis, oculoglandular syndrome,   endogenous panuveitis, 
vitreous hemorrhage, panuveitis with occlusive vasculitis, and 
chorioretinitis have also been reported.8,9,12,16,33,34 Our patients 
had choroiditis, vasculitis, central retinal vein occlusion, 
B A
Figure 2 (A and B) Case 4. Angiogram of both eyes shows papillary, peri-papillary, 
and choroidal fluorescence along the superior and inferior arcades. The macula area 
of the left eye also shows staining along the superior peri-foveal region.
D C
Figure 2 (C and D) Case 4. After treatment with sulfonamides, doxycycline, and 
ciprofloxacin, the angiogram of both eyes show normal disc fluorescence. There is 
no choroidal staining and no angiographic evidence of macular edema.
Figure 1 (A) Case 5. Fundus photo of the right eye shows a hyperemic disc with 
slightly indistinct borders especially nasally. The arteries are attenuated and the veins 
exhibit severe dilation and tortuosity with focal constrictions at areas of arterio-venous 
crossings. The posterior pole shows multiple intraretinal hemorrhages and cottonwool 
spots and retinal thickening. The perifoveal vessels are also dilated and tortuous and the 
foveal reflex is dull. There is a white-centered hemorrhage at the fovea. 
Figure 3 (A) Case 2. Angiogram of the left eye shows masking of the retinal, 
choiroidal, and disc fluorescence, which is due to vitreous haze (vitritis). The veins 
are slightly dilated with simultaneous laminar filling of the superior and inferior 
temporal arcades. The perifoveal vessels appear dilated.
Figure 1 (B) Case 5. After treatment with sulfonamides and doxycycline, fundus 
photo shows that disc vessels are still dilated, but with distinct disc borders. There is 
marked decrease in vessel tortuosity and dilation. There is also an evident decrease 
in retinal edema and hemorrhages as compared to Figure 1A.Clinical Ophthalmology 2011:5 submit your manuscript | www.dovepress.com
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eventually decreased to 1/640.33 The patient denied contact 
with animals or tick bite, like some of our patients. It is 
important to note the lack of antibodies to other Rickettsiae 
at the time Bonnet’s article was published, thus it is possible 
that any of the spotted fever group Rickettsia could have 
caused those findings.33
In Case 4, birdshot choroidopathy was diagnosed after 
clinical diagnosis and being positive with HLA-A29. However 
the patient did not improve after immunosuppressive therapy 
and had concomitant high IgG anti-R. conorii titers. Ocular 
inflammation improved and IgM and IgG anti-R. conorii 
titers decreased after three antibiotic courses, thus supporting 
our diagnosis of R. conorii infection. Cross reactivity with 
the HLA-A29 antigen has previously been considered in 
similar cases of birdshot choroidopathy with B. burgdorferi 
and Coxiella burnetti, formerly classified as a member of 
the order Rickettsiales,23 but not with R. conorii.35,36 The 
hypothesis of molecular mimicry has been proposed to 
explain the link between Gram negative bacteria and HLA-
B27 in the pathogenesis of ankylosing spondylitis.37 This 
could explain the association between tickborne bacteria, like 
R. conorii, C. burnetti, and B. burgdorferi, and HLA-A29 in 
the pathogenesis of birdshot choroidopathy. However this 
patient came from an area where rickettsiosis is endemic. 
Further, she showed high titers of anti-R. conorii IgM and 
IgG, which would argue against possible cross reactivity.
Since pure ocular rickettsiosis has already been reported 
for R. conorii, we believe all cases, except Case 2, represent 
R. conorii infection limited to the eye. They all had ocular 
inflammation and positive anti-R. conorii IgG and/or IgM 
titers that are compatible with European criteria for R. conorii 
infection and which decreased after antibiotic treatment.
Based on the clinical and serologic progress of these 
seven rare cases, they epitomize uveitis by spotted fever 
group Rickettsias as the main manifestation of the disease. 
The fact that most patients came from known endemic 
areas led us to conclude that R. conorii should be always 
considered as a cause of uveitis in Spain and most likely 
in other   Mediterranean countries. Although R. conorii 
was not reported as a common cause in a recent study on 
uveitis patterns in various geographic regions, we believe 
this   bacterium and related species should be included in 
the work-up of patients with uveitis who live in endemic 
areas.38
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